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Coronavirus Classification
• Alpha
– human examples:  hcov -229E, hcov -NL63 
– pig, dog, and cat  covs
• beta
– hcov -OC43, hcov -HKU1, hcov -SARS
– MHV, rat, pig and cow covs
– mers-cov
• gamma
– chicken and turkey  covs
• delta
– bird covs
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Coronaviruses (CoVs):
Features of Coronaviruses
Enveloped  positive strand RNA 
virushuman covs isolated in the 
1960s.
six human covs (hcovs) have been 
identified to date:
– hcov -229E
– hcov -OC43
– hcov -NL63
– hcov -HKU1
– sars-cov
– Middle east respiratory 
syndrome 
coronavirus (mers-cov)
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Non-sars Human Covs: 
Epidemiology
Non-SARS Human CoVs:
Clinical Spectrum of 
Illness
• Worldwide 
• Winter and spring in 
temperate climates 
• Exposure common in early 
childhood 
• Droplet, contact, and 
indirect contact 
• Symptoms and viral loads 
high first few days of illness 
• Incubation period 2–5 days
• Most often associated 
with upper respiratory tract 
infections in children 
• Pneumonia and lower
tract infections in 
immunocompromised
individuals and the elderly 
• May play a role in 
exacerbations of underlying 
respiratory diseases 
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Severe Acute Respiratory 
Syndrome (SARS)
SARS
• First recognized Nov, 2002 as 
sporadic cases in Guandong
province, China 
• Outbreak period 2002–2003
• Hong Kong hotel contributed to 
spread of virus to several 
countries 
• 8,098 probable SARS cases 
–774 deaths (10%)
Epidemiology
• incubation period 2-7 (max 
10) days
• viral shedding peaks 6-10 
days after onset of symptoms
• droplet spread
• less infectious than influenza
• Most transmission via close 
contact with a symptomatic 
person via large respiratory 
droplets. Transmission by 
fomites possible.
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Clinical course -
triphasic
Week 1
• fever, myalgia, 
systemic symptoms 
that improve after a 
few days
Week 2
• Fever returns, 
oxygen 
desaturation
• Later
• 20% get ARDS 
needing ventilation
SARS - morbidity
• Most cases are in healthcare 
workers caring for SARS 
patients and close family 
members of SARS patients
• overall mortality 15%
• mortality increases with age 
(> 65 years - 50% mortality)
• children seem to develop 
mild illness
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SARS diagnosis
• Clinical findings of 
an atypical 
pneumonia not 
attributed to other 
causes
• PCR positive for SARS 
CoV
• Seroconversion (gold 
standard)
SARS - treatment
• Supportive
• avoid aerosol inducing 
interventions
• evidence base for anti-
viral drugs lacking
• steroids may be helpful
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Key points in 
control of disease
• early case detection
• swift isolation
• thorough control of infection 
measures
• vigorous identification and 
management of close contacts 
by home confinement
• public information for those at 
risk of infection
• education of health care 
professionals
Personal 
protective 
• Masks
• Waterproof long 
sleeved gowns
• Gloves 
• Goggles 
• Centrally sourced 
and distributed
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Middle East Respiratory 
SyndromeBackground
• First identified in September, 
2012
• Cases retrospectively 
identified as early as March 
2012
• Different from other 
coronaviruses in humans, 
including SARS
• Most similar to 
coronaviruses found in bats 
First Reported MERS-CoV Case
• 60 year-old man from Saudi Arabia 
• 7 days of fever, cough, shortness of 
breath
Second Case
• 49 year-old man from Qatar
–Recent travel to Saudi Arabia
–History of farm (camels and sheep) exposure
• 6 days of cough, myalgia and arthralgia
• Admitted to Qatari hospital with bilateral 
pneumonia
• Transferred to London for respiratory and renal 
failure
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MERS-CoV
Origins
• Several studies have 
identified mers-cov in high 
proportion of camels.
• Until more is understood 
about MERS, people with 
diabetes, renal failure, 
chronic lung disease, and 
immunocompromised
persons are considered at 
high risk of severe disease 
from MERS-CoV infection. 
• Therefore , these people 
should avoid contact with 
camels,should not drink 
raw camel milk or camel
urine, and should not eat 
meat that has not been 
properly cooked.
• Identical gene segment found 
in one bat.
• Mode of transmission unclear
–Respiratory? Foodborne?
–Few primary cases with direct 
camel contact 
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Clinical
• • Range of presentations*
–62% severe respiratory illness
–5% mild symptoms
–21% asymptomatic
• Data from early cases
–High mortality 
–Lower respiratory tract 
illness, fever
• Data from more recent cases
–Lower mortality
–Higher proportion with upper 
respiratory tract illness
• No vaccine, no specific 
treatment
Transmission
• (19% of all cases)
–mostly healthcare 
workers–many
• with no or minor symptoms
• many clusters identified
–healthcare
–household (estimated 1.3% 
secondary attack rate)
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Epidemiology
• Case demographics
–65% male
–Median age 49 years (9 
months–94 years)
• Incubation period 2–14
days
• Infectious period
–Under investigation
–Not believed contagious 
before onset
Current Status*
• 614 cases*
–181 deaths (29%)
• Majority of case in Saudi 
Arabia 
• Other affected countries 
–United Arab Emirates, 
Qatar, Oman, Jordan, 
Kuwait, Yemen, Lebanon
–UK, France, Turkey, Tunisia, 
Italy, Greece, Malaysia, 
USA, Egypt, Netherlands
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Infection Control
• • Healthcare settings
–Contact, droplet and 
airborne isolation 
• Gowns, gloves and eye 
protection
• Negative-pressure 
airborne infection isolation
–Surgical mask when out of 
room 
• Home
–Follow guidance for ill 
persons, care givers and 
close contacts
Environmental 
Infection Control
• Follow  standard 
procedures, per hospital 
policy and manufacturers’ 
instructions, for cleaning 
and/or disinfection of:
• – Environmental surfaces 
and equipment 
• – Textiles and laundry
• – Food utensils and 
dishware
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Laboratory Testing
• • Lower respiratory 
specimens (sputum, 
bronchoalveolar lavage, 
endotracheal) are a priority 
respiratory specimen for RT 
-PCR testing.
• Respiratory (lower and 
upper tracts), stool, and 
serum specimens.
• Specimen collection at 
different times.
Approach to Serology
• • Identify and generate 
candidate cov antigens 
– using proteins from 
similar bat viruses
• develop ELISA-based 
assay
• evaluate assay with an 
extensive panel of negative 
(specificity) and positive 
sera (sensitivity)
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Therapeutics
.MERS CoV: Interferon alpha 
2b + ribavirin in vitro1.
.Recent study in Macaque 
monkeys2.
.No clear data on human 
treatment .
. Individuals with MERS can 
seek medical care to help 
relieve symptoms
. For severe cases, current 
treatment includes care to 
support vital organ functions
Vaccines
.SARS vaccines were in 
development
.Possible MERS vaccines:
VLP/nanoparticles with S 
protein
.Constitutive expression of S 
protein in cell culture
Developmental stages
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